drugset / Trial / NCT04311476

Autologous Cord Blood Cells for Prevention of BPD in Preterm

NCT04311476 ↗

Phase 2 Completed 62 enrolled yangjie
RandomizedParallel-groupDouble-blindPrevention

Summary

To study the effect of Autologous cord blood cells infusion on prevention of bronchopulmonary dysplasia in very preterm neonates

Timeline

Start
2018-07-01
Primary completion
2020-01-01
Completion
2020-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Umbilical Cord Blood Mononuclear Cells Cell therapy 5e+07 cells/kg Intravenous